Symbols

PAYS

Paysign·NASDAQ

--(--)

PAYS fundamentals

PAYS Q4 2025 Earnings

Paysign (PAYS) released its earnings on Mar 24, 2026: revenue was 22.76M (YoY +45.81%), beat estimates; EPS was 0.02 (YoY 0.00%), met estimates.

Revenue / YoY

22.76M

+45.81%

EPS / YoY

0.02

0.00%

Report date

Mar 24, 2026

PAYS Earnings Call Summary for Q4,2025

Revenue Growth: 40.5% YoY to $82 million, with pharma industry revenue surging 167.8%.
Profitability: Net income up 98% to $7.6 million, operating margin expands to 9%.
Patient Affordability Dominance: 79% claims growth, $150M client savings, and 55 new programs added.
2026 Outlook: $106.5-$110.5M revenue target, 60-62% gross margin, and 20% operating expense growth.
Strategic Strengths: 97% maximizer detection rate, payments tech differentiation, and $150M+ client savings.

Earnings

EPS

Revenue

Revenue & Expenses

PAYS has released its 2025 Q3 earnings report, with revenue of 21.60M, reflecting a YoY change of 41.56%, and net profit of 2.22M, showing a YoY change of 54.17%. The Sankey diagram below clearly presents PAYS's revenue sources and cost distribution.

Key Indicators

Paysign (PAYS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Paysign (PAYS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Paysign (PAYS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Paysign (PAYS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown